{"title":"Evaluation of Outcomes of Pregnancy in Women with Eisenmenger Syndrome: Is There Any Prognostic Criterion?","authors":"Dilek Çiçek Yılmaz, Gülten Taçoy","doi":"10.5543/tkda.2024.40963","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Pregnancy in women with Eisenmenger syndrome (ES) presents very high morbidity and mortality rates for both the mother and fetus. In this study, we aimed to evaluate the outcomes of pregnancies affected by ES.</p><p><strong>Methods: </strong>This retrospective cohort study reviewed pregnancies in women with ES at two university hospitals over the past 10 years. The primary outcomes examined were maternal, perinatal, and pregnancy-related outcomes in women with ES.</p><p><strong>Results: </strong>The study enrolled eight pregnant women diagnosed with ES. The average maternal age was 26.7 years (range 21-36 years). The causes of ES included ventricular septal defect (five patients), patent ductus arteriosus (two patients), and atrial septal defect (one patient). Four patients had been diagnosed with ES before pregnancy. Two patients died in this group; one developed right heart failure in the third trimester and unfortunately died immediately after delivery due to cardiogenic shock, and another died on the 10th postpartum day from sudden cardiac arrest despite having had a successful delivery. Four patients were diagnosed with ES during the postpartum period; none in this group died, and there were no cases of fetal mortality. We could not identify any clinical or echocardiographic predictors for postpartum mortality. The two deceased patients showed tendencies of severe right heart failure and lower oxygen saturation during the third trimester and before delivery.</p><p><strong>Conclusion: </strong>Despite advanced obstetric care and targeted treatments for pulmonary arterial hypertension, maternal mortality is still unacceptably high in patients with ES. No significant predictors of maternal mortality were identified.</p>","PeriodicalId":94261,"journal":{"name":"Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5543/tkda.2024.40963","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Pregnancy in women with Eisenmenger syndrome (ES) presents very high morbidity and mortality rates for both the mother and fetus. In this study, we aimed to evaluate the outcomes of pregnancies affected by ES.
Methods: This retrospective cohort study reviewed pregnancies in women with ES at two university hospitals over the past 10 years. The primary outcomes examined were maternal, perinatal, and pregnancy-related outcomes in women with ES.
Results: The study enrolled eight pregnant women diagnosed with ES. The average maternal age was 26.7 years (range 21-36 years). The causes of ES included ventricular septal defect (five patients), patent ductus arteriosus (two patients), and atrial septal defect (one patient). Four patients had been diagnosed with ES before pregnancy. Two patients died in this group; one developed right heart failure in the third trimester and unfortunately died immediately after delivery due to cardiogenic shock, and another died on the 10th postpartum day from sudden cardiac arrest despite having had a successful delivery. Four patients were diagnosed with ES during the postpartum period; none in this group died, and there were no cases of fetal mortality. We could not identify any clinical or echocardiographic predictors for postpartum mortality. The two deceased patients showed tendencies of severe right heart failure and lower oxygen saturation during the third trimester and before delivery.
Conclusion: Despite advanced obstetric care and targeted treatments for pulmonary arterial hypertension, maternal mortality is still unacceptably high in patients with ES. No significant predictors of maternal mortality were identified.
目的:患有艾森曼格综合征(ES)的妇女怀孕后,母亲和胎儿的发病率和死亡率都非常高。本研究旨在评估艾森曼格综合征孕妇的妊娠结局:这项回顾性队列研究回顾了两所大学医院在过去 10 年中妊娠的 ES 妇女。研究的主要结果是 ES 妇女的母体、围产期和妊娠相关结果:研究共纳入了 8 名确诊为 ES 的孕妇。产妇平均年龄为 26.7 岁(21-36 岁不等)。导致 ES 的原因包括室间隔缺损(5 名患者)、动脉导管未闭(2 名患者)和房间隔缺损(1 名患者)。四名患者在怀孕前就被诊断出患有 ES。这组患者中有两人死亡,其中一人在怀孕三个月时出现右心衰竭,不幸在分娩后因心源性休克立即死亡,另一人虽然顺利分娩,但在产后第 10 天因心脏骤停死亡。四名患者在产后期间被诊断出患有 ES,但其中无人死亡,也没有胎儿死亡病例。我们无法确定产后死亡的临床或超声心动图预测因素。两名死亡患者在第三孕期和分娩前出现严重右心衰竭和血氧饱和度降低的趋势:结论:尽管有先进的产科护理和针对肺动脉高压的治疗方法,但 ES 患者的孕产妇死亡率仍然高得令人无法接受。没有发现孕产妇死亡率的重要预测因素。